Enhancing Capital’s Colgate-Palmolive CL Stock Holding History

Enhancing Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$367K	Hold	4,000	–	–	0.25%	68
2026 Q1	$341K	Hold	4,000	–	–	0.25%	71
2025 Q4	$316K	Hold	4,000	–	–	0.23%	76
2025 Q3	$320K	Hold	4,000	–	–	0.23%	74
2025 Q2	$364K	Hold	4,000	–	–	0.28%	76
2025 Q1	$375K	Hold	4,000	–	–	0.3%	76
2024 Q4	$364K	Buy	+4,000	New	+$382K	0.29%	74
2022 Q3	$276K	Hold	4,000	–	–	0.34%	65
2022 Q2	$321K	Hold	4,000	–	–	0.38%	59
2022 Q1	$303K	Hold	4,000	–	–	0.32%	67
2021 Q4	$341K	Buy	+4,000	New	+$312K	0.37%	63

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Enhancing Capital's CL Position: Q2 2026 in Review

Enhancing Capital held its Colgate-Palmolive (CL) position steady in Q2 2026 at 4,000 shares worth $367K. The position accounts for 0.25% of the portfolio, ranked #68.

Enhancing Capital first reported a position in CL in Q4 2021 and has held it in 11 quarters since. The position peaked at $375K in Q1 2025. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Enhancing Capital held 4,000 shares of Colgate-Palmolive worth $367K as of Q2 2026.
Enhancing Capital left its Colgate-Palmolive share count unchanged in Q2 2026.
Colgate-Palmolive made up 0.25% of Enhancing Capital's portfolio in Q2 2026, its #68 holding.
Enhancing Capital first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 11 quarters since.
Enhancing Capital's Colgate-Palmolive position peaked at $375K in Q1 2025.
2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Enhancing Capital's 13F filing for Q2 2026, filed 11 Aug 2026.